• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

决策与前列腺癌筛查。

Decision making and prostate cancer screening.

机构信息

Health Services Research and Development Service, Office of Research and Development, Veterans Health Administration, 810 Vermont Avenue, Northwest, Washington, DC 20420, USA; Department of Psychiatry, University of California San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143, USA; Department of Urology, University of California San Francisco, 400 Parnassus Avenue, Suite A610, San Francisco, CA 94123, USA.

出版信息

Urol Clin North Am. 2014 May;41(2):257-66. doi: 10.1016/j.ucl.2014.01.008. Epub 2014 Feb 28.

DOI:10.1016/j.ucl.2014.01.008
PMID:24725488
Abstract

This article presents an overview of the challenges that men encounter in making decisions about prostate cancer screening, including complex affective and cognitive factors and controversies in the interpretation of the evidence on prostate cancer screening. Shared decision making involving patient decision aids are discussed as approaches that can be used to improve the quality of prostate cancer screening decisions, including a close alignment between a man's values, goals, and preferences and his choice about screening.

摘要

本文概述了男性在决定是否进行前列腺癌筛查时所面临的挑战,包括复杂的情感和认知因素,以及前列腺癌筛查证据解读方面的争议。本文还讨论了共同决策,包括使用患者决策辅助工具,这些方法可以用来提高前列腺癌筛查决策的质量,包括使男性的价值观、目标和偏好与其筛查选择密切一致。

相似文献

1
Decision making and prostate cancer screening.决策与前列腺癌筛查。
Urol Clin North Am. 2014 May;41(2):257-66. doi: 10.1016/j.ucl.2014.01.008. Epub 2014 Feb 28.
2
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?使用前列腺特异性抗原检测筛查前列腺癌:患者是否在做出明智的决策?
J Fam Pract. 1999 Sep;48(9):682-8.
3
Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).前列腺癌筛查决策:全国医疗决策调查(DECISIONS研究)结果
Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.
4
A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.一项基于社区的干预措施,旨在促进西班牙裔美国男性对前列腺癌筛查的知情决策:一项群组 RCT 研究。
Patient Educ Couns. 2011 Aug;84(2):e44-51. doi: 10.1016/j.pec.2010.07.033. Epub 2011 Jan 14.
5
Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.基于 PSA 检测前列腺癌的知情决策:风险指标传单评估。
Eur J Cancer. 2010 Feb;46(3):669-77. doi: 10.1016/j.ejca.2009.11.022.
6
National evidence on the use of shared decision making in prostate-specific antigen screening.国家关于在前列腺特异性抗原筛查中使用共同决策的证据。
Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.
7
American Cancer Society guideline for the early detection of prostate cancer: update 2010.美国癌症协会前列腺癌早期检测指南:2010 年更新版。
CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3.
8
Prostate-specific antigen screening: friend or foe?前列腺特异性抗原筛查:是福是祸?
Urol Nurs. 2007 Dec;27(6):481-9; quiz 490.
9
Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.影响初级保健医生决定为无前列腺癌男性开具前列腺特异性抗原(PSA)检测的因素。
Acta Oncol. 2013 Nov;52(8):1602-8. doi: 10.3109/0284186X.2012.762998. Epub 2013 Feb 19.
10
Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.前列腺癌的知情决策与前列腺特异性抗原(PSA)检测:一项随机对照试验,探讨简短患者决策辅助工具对男性关于检测的知识、态度及意愿的影响。
Patient Educ Couns. 2006 Nov;63(3):367-79. doi: 10.1016/j.pec.2006.05.005. Epub 2006 Jul 27.

引用本文的文献

1
Patient Communication Preferences for Prostate Cancer Screening Discussions: A Scoping Review.患者对前列腺癌筛查讨论的沟通偏好:范围综述。
Ann Fam Med. 2023 Sep-Oct;21(5):448-455. doi: 10.1370/afm.3011.
2
The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD).前列腺腺癌(PRAD)中吞噬调节因子的预后特征及治疗价值
Front Genet. 2022 May 30;13:877278. doi: 10.3389/fgene.2022.877278. eCollection 2022.
3
The Relation among Prostate Cancer Knowledge and Psychosocial Factors for Prostate Cancer Screening among African American Men: a Correlational Study.
非裔美国男性前列腺癌知识与前列腺癌筛查心理社会因素之间的关系:一项相关性研究。
AIMS Public Health. 2017 Oct 25;4(5):446-465. doi: 10.3934/publichealth.2017.5.446. eCollection 2017.
4
Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.检查多媒体干预对新诊断前列腺癌患者治疗决策的影响:一项全国 RCT 的结果。
Transl Behav Med. 2018 Nov 21;8(6):876-886. doi: 10.1093/tbm/iby066.
5
Impact of numeracy on understanding of prostate cancer risk reduction in PSA screening.算术能力对前列腺特异性抗原筛查中前列腺癌风险降低理解的影响。
PLoS One. 2017 Dec 28;12(12):e0190357. doi: 10.1371/journal.pone.0190357. eCollection 2017.
6
Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.三个州的前列腺癌筛查决策:2013年行为危险因素监测系统分析
Cancer Causes Control. 2017 Mar;28(3):235-240. doi: 10.1007/s10552-017-0860-8. Epub 2017 Feb 16.
7
Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues.利用光声光谱分析对 Gleason 评分进行量化:人体组织可行性研究
Biomed Opt Express. 2015 Nov 9;6(12):4781-9. doi: 10.1364/BOE.6.004781. eCollection 2015 Dec 1.
8
Prostate cancer screening: going beyond the clinical evidence.前列腺癌筛查:超越临床证据
CMAJ. 2014 Nov 4;186(16):1201-2. doi: 10.1503/cmaj.141252. Epub 2014 Oct 27.
9
Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.原钙黏蛋白17异常甲基化及其在前列腺癌根治术后患者中的临床意义
Med Sci Monit. 2014 Aug 5;20:1376-82. doi: 10.12659/MSM.891247.